Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 59.35
+0.50 (0.85%)
Apr 29, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 24,226 | 34,157 | 29,847 | 21,296 | 15,837 | 11,911 | Upgrade
|
| Market Cap Growth | -23.65% | 14.44% | 40.15% | 34.47% | 32.96% | -14.13% | Upgrade
|
| Enterprise Value | 23,326 | 33,473 | 29,272 | 20,670 | 15,360 | 11,446 | Upgrade
|
| Last Close Price | 59.35 | 83.68 | 72.76 | 51.54 | 38.13 | 28.57 | Upgrade
|
| PE Ratio | 24.06 | 33.12 | 36.06 | 38.34 | 55.18 | 65.73 | Upgrade
|
| Forward PE | 18.98 | 28.12 | 28.12 | 28.12 | 28.12 | 28.12 | Upgrade
|
| PS Ratio | 6.34 | 9.24 | 10.60 | 10.14 | 10.37 | 10.52 | Upgrade
|
| PB Ratio | 6.67 | 9.90 | 11.69 | 11.35 | 11.25 | 10.26 | Upgrade
|
| P/TBV Ratio | 7.52 | 11.29 | 12.53 | 12.64 | 12.32 | 11.74 | Upgrade
|
| P/FCF Ratio | 62.81 | 72.18 | 166.48 | 95.23 | 109.98 | 271.61 | Upgrade
|
| P/OCF Ratio | 36.87 | 46.83 | 69.31 | 41.59 | 43.61 | 50.73 | Upgrade
|
| EV/Sales Ratio | 6.11 | 9.06 | 10.39 | 9.84 | 10.06 | 10.11 | Upgrade
|
| EV/EBITDA Ratio | 17.58 | 25.22 | 29.29 | 28.98 | 38.09 | 43.97 | Upgrade
|
| EV/EBIT Ratio | 19.54 | 27.58 | 31.46 | 31.32 | 42.66 | 51.64 | Upgrade
|
| EV/FCF Ratio | 60.47 | 70.73 | 163.28 | 92.42 | 106.67 | 260.99 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.14 | 0.13 | 0.01 | 0.01 | 0.02 | 0.10 | Upgrade
|
| Debt / FCF Ratio | 0.48 | 0.37 | 0.05 | 0.04 | 0.07 | 0.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.24 | -0.26 | -0.35 | -0.40 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.68 | -0.63 | -0.65 | -0.93 | -1.39 | -1.75 | Upgrade
|
| Net Debt / FCF Ratio | -2.33 | -1.77 | -3.64 | -2.96 | -3.90 | -10.41 | Upgrade
|
| Asset Turnover | 1.00 | 1.00 | 1.04 | 1.02 | 0.96 | 0.87 | Upgrade
|
| Inventory Turnover | 0.83 | 0.77 | 0.82 | 0.89 | 1.39 | 1.18 | Upgrade
|
| Quick Ratio | 3.92 | 3.23 | 3.55 | 2.80 | 3.04 | 4.01 | Upgrade
|
| Current Ratio | 4.79 | 3.86 | 4.34 | 3.32 | 3.57 | 4.71 | Upgrade
|
| Return on Equity (ROE) | 31.78% | 34.36% | 37.37% | 33.83% | 22.35% | 16.77% | Upgrade
|
| Return on Assets (ROA) | 19.52% | 20.43% | 21.51% | 19.99% | 14.09% | 10.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 39.56% | 47.22% | 53.10% | 55.56% | 37.47% | 29.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 30.70% | 33.10% | 35.40% | 33.80% | 24.00% | 17.80% | Upgrade
|
| Earnings Yield | 4.18% | 3.02% | 2.77% | 2.61% | 1.81% | 1.52% | Upgrade
|
| FCF Yield | 1.59% | 1.39% | 0.60% | 1.05% | 0.91% | 0.37% | Upgrade
|
| Dividend Yield | 1.05% | 0.74% | 0.85% | 0.80% | 0.56% | 0.35% | Upgrade
|
| Payout Ratio | 24.99% | 24.52% | 20.15% | 15.60% | 14.17% | 11.41% | Upgrade
|
| Buyback Yield / Dilution | -0.64% | -0.38% | -0.56% | -0.29% | -0.39% | -0.18% | Upgrade
|
| Total Shareholder Return | 0.43% | 0.36% | 0.30% | 0.50% | 0.17% | 0.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.